Authors: Hu, Shimin, Xu-Monette, Zijun Y, Balasubramanyam, Aarthi, Manyam, Ganiraju C, Visco, Carlo, Tzankov, Alexander, Liu, Wei-min, Miranda, Roberto N, Zhang, Li, Montes-Moreno, Santiago, Dybkær, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L, Hsi, Eric D, Choi, William WL, Han van Krieken, J, Huang, Qin, Huh, Jooryung, Ai, Weiyun, Ponzoni, Maurilio, Ferreri, Andrés JM, Zhao, Xiaoying, Winter, Jane N, Zhang, Mingzhi, Li, Ling, Møller, Michael B, Piris, Miguel A, Li, Yong, Go, Ronald S, Wu, Lin, Medeiros, L Jeffrey, Young, Ken H
Subject Terms: Humans, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone, Antigens, CD30, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Prognosis, Disease-Free Survival, Treatment Outcome, Multivariate Analysis, Survival Analysis, Follow-Up Studies, Gene Expression Regulation, Neoplastic, Middle Aged, Female, Male, Lymphoma, Large B-Cell, Diffuse, Antibodies, Monoclonal, Murine-Derived, Transcriptome, Rituximab
File Description: application/pdf
Relation: Blood; blood-2012-10-461848; https://hdl.handle.net/10161/19328
Availability: https://hdl.handle.net/10161/19328
Authors: Xu-Monette, Zijun Y, Wu, Lin, Visco, Carlo, Tai, Yu Chuan, Tzankov, Alexander, Liu, Wei-min, Montes-Moreno, Santiago, Dybkaer, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L, Hsi, Eric D, Zhao, X Frank, Choi, William WL, Zhao, Xiaoying, van Krieken, J Han, Huang, Qin, Huh, Jooryung, Ai, Weiyun, Ponzoni, Maurilio, Ferreri, Andrés JM, Zhou, Fan, Kahl, Brad S, Winter, Jane N, Xu, Wei, Li, Jianyong, Go, Ronald S, Li, Yong, Piris, Miguel A, Møller, Michael B, Miranda, Roberto N, Abruzzo, Lynne V, Medeiros, L Jeffrey, Young, Ken H
Subject Terms: Humans, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Staging, Prognosis, Treatment Outcome, Cohort Studies, Gene Expression Profiling, Computational Biology, Gene Expression Regulation, Neoplastic, Gene Deletion, Mutation, Loss of Heterozygosity, Missense, Alleles, Exons, Adult, Aged, Middle Aged, Female, Male, Tumor Suppressor Protein p53, Lymphoma, Large B-Cell, Diffuse, Antibodies
File Description: application/pdf
Relation: Blood; blood-2012-05-433334; https://hdl.handle.net/10161/19327
Availability: https://hdl.handle.net/10161/19327
Authors: Hu, Shimin, Xu-Monette, Zijun Y, Tzankov, Alexander, Green, Tina, Wu, Lin, Balasubramanyam, Aarthi, Liu, Wei-min, Visco, Carlo, Li, Yong, Miranda, Roberto N, Montes-Moreno, Santiago, Dybkaer, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L, Hsi, Eric D, Choi, William WL, Zhao, Xiaoying, van Krieken, J Han, Huang, Qin, Huh, Jooryung, Ai, Weiyun, Ponzoni, Maurilio, Ferreri, Andrés JM, Zhou, Fan, Slack, Graham W, Gascoyne, Randy D, Tu, Meifeng, Variakojis, Daina, Chen, Weina, Go, Ronald S, Piris, Miguel A, Møller, Michael B, Medeiros, L Jeffrey, Young, Ken H
Subject Terms: B-Lymphocyte Subsets, Humans, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone, Proto-Oncogene Proteins c-myc, Proto-Oncogene Proteins c-bcl-2, Antineoplastic Combined Chemotherapy Protocols, Prognosis, Risk Factors, Survival Analysis, Retrospective Studies, Cohort Studies, Lymphocyte Activation, Gene Expression Regulation, Neoplastic, International Cooperation, Adult, Aged, 80 and over, Middle Aged, Female, Male, Lymphoma, Large B-Cell, Diffuse, Antibodies, Monoclonal, Murine-Derived
File Description: application/pdf
Relation: Blood; blood-2012-10-460063; https://hdl.handle.net/10161/19329
Availability: https://hdl.handle.net/10161/19329